Credit Analysis: Aether Limited (06630896)

1. Credit Opinion: APPROVE

Rationale: Aether Limited presents an exceptionally strong credit profile characterised by a debt-free balance sheet, substantial cash reserves of £1.6M, and consistent equity growth over a 17-year trading history. The current ratio of approximately 8:1 demonstrates outstanding liquidity, and net assets have grown from £300k (2016) to £2.08M (2025), evidencing sustained profitability and prudent financial management. The company operates in a knowledge-intensive sector (R&D in natural sciences and engineering) with a growing workforce, suggesting a viable and expanding business model.

2. Financial Strength

Balance Sheet Summary:

Key Observations:

• Equity Base: Net assets have grown nearly sevenfold over the past decade (£300k in 2016 to £2.08M in 2025), reflecting strong retained profitability
• No Borrowings: The balance sheet shows no bank loans, overdrafts, or long-term debt obligations. The company is entirely equity-funded
• Share Capital: Minimal at £4, indicating the entire capital base has been built through retained earnings – a positive indicator of self-sustaining profitability
• Asset Quality: Cash represents 67% of total assets, providing exceptional asset liquidity. Fixed assets are modest at £40k, indicating an asset-light business model typical of professional/R&D services
• Group Structure: Note 2.2 references "Livens Holdings Ltd" as the parent entity. The subsidiary investment is carried at £5,016. Group-level exposures should be considered if lending on a group basis

Long-term Trajectory: Consistent and impressive growth trajectory, though growth has moderated in recent years (net assets were £2.16M in 2023 before a slight decline).

3. Cash Flow Assessment

Liquidity Position:

Working Capital Analysis:

• Current Ratio: At 8.1x, liquidity is exceptionally strong and far exceeds typical requirements. The company can comfortably meet all short-term obligations multiple times over
• Cash Position: £1.6M in cash provides approximately 5.5x coverage of current liabilities – outstanding by any measure
• Trade Debtors: Increased significantly from £440k (2024) to £659k (2025), a 49% rise. This warrants investigation – it could indicate revenue growth or potential collection issues
• Trade Creditors: Decreased from £68k to £60k, suggesting the company is paying suppliers promptly
• Tax & Social Security: Increased from £137k to £195k, likely reflecting higher profitability and payroll costs (employee count grew from 35 to 40)

Cash Flow Concerns: - Cash declined by £58k (3.5%) while debtors increased by £218k. This divergence may indicate working capital pressure from growing receivables, though the absolute cash position remains very strong - The 2023 cash position was £1.93M, meaning cash has declined by £327k over two years while debtors have increased. This pattern suggests the business is funding growth through its cash reserves

4. Monitoring Points

1. Trade Debtors Growth: The 49% increase in trade debtors year-on-year is material. Monitor debtor days and ageing profiles to ensure credit quality is maintained. If debtor days are extending, this could signal collection risk or aggressive revenue recognition

2. Cash Trajectory: Cash has declined from £1.93M (2023) to £1.60M (2025). While still substantial, a continued downward trend could indicate the business is consuming cash to fund growth. Establish thresholds for concern (e.g., cash falling below £1M)

3. Group Exposures: The company is a subsidiary of Livens Holdings Ltd. Understand the group structure, inter-company balances (£17.7k owed by group undertakings), and whether any group-level obligations could create contingent liabilities

4. Revenue Visibility: The filed accounts are filleted (no P&L), so revenue and profitability trends are not directly observable. Request management accounts to verify top-line growth and margin stability

5. Employee Costs: Headcount grew from 35 to 40 (14% increase). In a knowledge-based R&D business, payroll is likely the largest cost. Monitor whether revenue growth keeps pace with staffing increases

6. Sector Risk: Operating in natural sciences R&D (SIC 72190) may involve project-based revenue with potential cyclicality. Understand contract structures and revenue visibility for the next 12-24 months

7. Deferred Tax: The deferred tax provision increased from £7.9k to £9.1k. While immaterial, confirm this relates to timing differences rather than uncertain tax positions